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Background: Canadian Aboriginal subjects have a higher prevalence of diabetes, renal disease, and lower extremity
amputation than non-Aboriginal subjects. However, limited information is available about patient outcomes for arterial
bypass surgery in Canadian Aboriginal compared with non-Aboriginal subjects.
Methods: A retrospective study of all patients undergoing revascularization for peripheral vascular disease at a tertiary care
referral center was performed.
Results: A total of 828 procedures were performed on 678 patients between 1995 and 2002: 108 (13%) procedures on 84
(12%) Aboriginal patients and 720 (87%) procedures on 594 (88%) non-Aboriginal patients. Aboriginal patients had a
higher prevalence of diabetes, chronic renal failure, and end-stage renal disease than non-Aboriginal patients. Aboriginal
patients presented with more serious complications (gangrene [Aboriginal, 63 {58%} of 108 patients; non-Aboriginal,
112 {16%} of 720 patients; P< .0001] and nonhealing ulcer [Aboriginal, 29 {27%} of 108 patients; non-Aboriginal, 131
{18%} of 720 patients; P < .05]) and required urgent or emergency revascularization (Aboriginal, 47 [49%] of 95
patients; non-Aboriginal, 228 [36%] of 634 patients; P < .02) more frequently than non-Aboriginal patients. The
60-month patient mortality was similar for both groups (Aboriginal, 20 [24%] of 84 patients; non-Aboriginal, 160
[27%] of 594 patients; not significant), but Aboriginal patients had loss of limb more frequently (Aboriginal, 19 [18%]
of 108 patients; non-Aboriginal, 62 [9%] of 720 patients; P < .0001) and had loss of primary graft patency more
frequently (Aboriginal, 39 [36%] of 108 patients; non-Aboriginal, 155 [22%] of 720 patients; P < .0001) than
non-Aboriginal patients.
Conclusions: Canadian Aboriginal subjects had worse outcomes with revascularization than non-Aboriginal subjects, but
ethnicity and diabetes were not independent risk factors for poor outcome. Multivariate analysis showed that the poor
outcomes in mortality, limb salvage, and primary graft patency among Aboriginal patients undergoing revascularization
may be attributed to renal disease and a more advanced mode of presentation of peripheral vascular disease complications
at the time of intervention. (J Vasc Surg 2006;43:735-41.)Peripheral vascular disease (PVD) is a condition with
a potential for devastating consequences. In developed
nations, it seems that minority populations not only have a
higher prevalence of PVD risk factors, but also have a
disproportionately higher rate of PVD and its complica-
tions.1-3 End-stage renal disease (ESRD), for example, is
more prevalent among minorities, and its presence entails a
dismal outcome for those with complications of PVD.4-7
Diabetes, a potent risk factor for the development of PVD
and its subsequent complications, has been shown to affect
minority populations at a higher rate than the general
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doi:10.1016/j.jvs.2005.11.058population.8-11 The frequency of lower extremity amputa-
tion (LEA) is 10 to 24 times higher in diabetic than in
nondiabetic subjects.12 In the Canadian province of Mani-
toba, 71% of all LEA procedures from 1990 to 1994 were
in diabetic patients.13
There is a higher prevalence of diabetes, ESRD, and
LEA in North American Indians (Aboriginals) and other
minority populations than in the white population.14-24
The age-adjusted prevalence of diabetes in adult Manito-
bans is threefold to fivefold greater in Aboriginal (men,
17%; women, 25%) than in non-Aboriginal (men, 5.6%;
women, 5.4%) people.25 Native Americans have a 2.8-fold
greater incidence of ESRD than whites, and this is 23 times
greater among the Pima Indians than in the general popu-
lation.17 In Canada, Aboriginals also have a disproportion-
ately high incidence of ESRD.26 Furthermore, in 1993 to
1994, 16% of LEA procedures in Manitoba were in Aborig-
inal people, who comprised only 10% of the popula-
tion.25,27
Limited information is available about patient out-
comes for arterial bypass surgery in Aboriginal compared
with non-Aboriginal Canadians. We hypothesized that the
results of revascularization surgery in Aboriginal patients
were worse than those in non-Aboriginal patients because
of a delay in treatment and a greater severity of diabetes and
vascular disease. The purpose of this study was to evaluate
735
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tions performed at a major Canadian referral center in
Manitoba by comparing patient, limb, and graft survival for
Aboriginal and non-Aboriginal patients.
MATERIALS AND METHODS
Subjects. A retrospective medical record review was
performed of a continuous series of 678 patients undergo-
ing 828 lower extremity bypass operations at a major
regional tertiary care referral center inManitoba from 1995
to 2002. Cases were identified from the hospital patient
database by identifying surgical procedure billing codes for
bypass surgery. This study was approved by the Research
Ethics Board at the Faculty of Medicine, University of
Manitoba.
Aboriginal people were the indigenous inhabitants of
Canada, including the First Nations (Indians), Inuit, and
Métis people, independent of their separate origins and
political or cultural identities.28 Aboriginal patients were
identified from their treaty numbers or from references
Table I. Risk factors for peripheral vascular disease in 678
bypass procedures*
Risk factor All patients Ab
Total No. (%) patients 678 (100%)
Age at bypass, y (mean  SD) 69  12
Diabetes 326 (48%)
CRF 79 (12%)
ESRD 48 (7%)
Hypertension 453 (67%)
Cardiac disease‡ 344 (51%)
Dyslipidemia 169 (25%)
Stroke 125 (18%)
Retinopathy 57 (8%)
Blindness 27 (4%)
Smoking§
n (%) 503 (74%)
Pack-years 40  23
CRF, Chronic renal failure, non–dialysis dependent; ESRD, end-stage rena
*Aboriginal: 108 (13%) procedures in 84 (12%) patients; non-Aboriginal: 7
†Comparison between total Aboriginal and total non-Aboriginal patients; N
‡Angina, myocardial infarction, or congestive heart failure.
§Includes current and former smokers.
Table II. Operative indications for 828 lower extremity v
Operative indications All patients Abor
Total No. (%) procedures 828 (100%) 1
Rest pain 444 (54%)
Claudication 215 (26%)
Gangrene‡ 175 (21%)
Nonhealing ulcer 160 (19%)
Acute ischemia 66 (8%)
*Aboriginal: 108 (13%) procedures in 84 (12%) patients; non-Aboriginal: 7
†Difference between total Aboriginal and total non-Aboriginal patients; NS
‡Gangrene in non-Aboriginal patients: difference between diabetic (84 [27
difference between patients with renal disease (35 [47%] of 75 patients) andmade to ethnicity in the medical record. All other patientswere classified as non-Aboriginal. Data were collected by
using a standardized form that included patient demo-
graphics, associated diseases, risk factors, and outcomes.
Diabetes (type 1 or 2) and chronic kidney disease were
noted, and patients with chronic kidney disease (defined as
having a glomerular filtration rate60 mL/min per 1.73 m2
for 3 months) were either not receiving dialysis (chronic
renal failure [CRF]) or were dialysis dependent (ESRD);
the duration of dialysis was unavailable because it was not
routinely documented in the hospital record. A history of
cardiac disease (angina, myocardial infarction, or conges-
tive heart failure), cerebrovascular accident, or hyperten-
sion was noted. The type and anatomic level of arterial
bypass were recorded; femoral to tibial and peroneal bypass
were grouped together, and all bypasss procedures from the
popliteal artery to arteries distal to the tibial and peroneal
arteries were categorized as popliteal-distal bypass. A major
amputation was defined as an amputation above the level of
the ankle. Limb salvage was defined as prevention of a
major amputation. The patency of a graft was determined
ents who had 828 lower extremity vascular
nal patients Non-Aboriginal patients P value†
(100%) 594 (100%) —
 11 70  12 .0001
(92%) 249 (42%) .0001
(27%) 30 (5%) .0001
(20%) 31 (5%) .0001
(70%) 394 (66%) NS
(49%) 303 (51%) NS
(32%) 142 (24%) NS
(20%) 108 (18%) NS
(12%) 47 (8%) NS
(8%) 20 (3%) .03
(71%) 443 (75%) NS
 16 41  23 NS
se, dialysis dependent.
7%) procedures in 594 (88%) patients.
t significant (P  .05).
ar bypass procedures in 678 patients*
l patients Non-Aboriginal patients P value†
00%) 720 (100%) —
0%) 401 (56%) .002
%) 206 (29%) .0001
8%) 112 (16%) .0001
7%) 131 (18%) .05
%) 59 (8%) NS
7%) procedures in 594 (88%) patients.
ignificant; P  .05.
309 patients) and nondiabetic (28 [7%] of 411 patients) was P  .0001;
e with no renal disease (77 [12%] of 645 patients) was P  .0001.pati
origi
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at the time of follow-up with a vascular surgeon; ankle-
brachial indices occasionally were followed according to clin-
ical indications. The urgency of an operation was determined
according to the classification assigned by the operating sur-
geon as elective, urgent (limb-threatening ischemia necessi-
tating intervention on same admission), or emergent (ne-
cessitating intervention within 24 hours). Smoking status at
the time of the arterial bypass procedure was documented
(never smoked, former smoker, or currently smoking).
Data analysis. Patient characteristics and patient sur-
vival were analyzed for differences between groups by both
univariate and multivariate analysis. Limb salvage, primary
graft patency, and procedure-specific characteristics were
analyzed for each procedure. Differences between Aborig-
inal and non-Aboriginal patients and differences between
subgroups by diabetes or renal status were compared by
using the two-tailed Student t test, Fisher exact test, or 2
test, and the level of significance was defined by P  .05.
Patient survival, limb salvage, and primary patency were
analyzed by using a life-table technique and by using Cox
proportional hazard modeling with estimates for hazard
ratios and 95% confidence intervals. For the life-table
graphs, patients who had died or were lost to follow-up
were removed from the population pool in the limb loss
and graft patency graphs. The values reported in the tables
included all patients; patients who died were considered to
have died with a patent graft.
RESULTS
The 84 (12%) Aboriginal and 594 (88%) non-Aboriginal
patients had similar number of operations per patient (Ab-
original, 1.3 operations per patient; non-Aboriginal, 1.2
operations per patient; not significant; Table I). Aboriginal
patients were significantly younger on average and had a
Table III. Procedure type for 828 lower extremity vascula
Procedure type All patients
Total No. (%) procedures 828 (100%)
Femorotibial/peroneal 229 (28%)
Femoropopliteal (BK) 167 (20%)
Aortofemoral 128 (15%)
Femoropopliteal (AK) 118 (14%)
Cross-femoral 102 (12%)
Popliteal-distal 63 (8%)
Femoropedal 21 (3%)
RSVG 105 (13%)
Amputation at or below ankle level
(at time of bypass procedure)
At least one toe 89 (11%)
Forefoot 8 (1%)
Elective  urgent  emergent‡ 729
Elective only 454 (62%)
BK, Below knee; AK, above knee; RSVG, reversed saphenous vein graft.
*All procedures: Aboriginal, 108 (13%) procedures in 84 (12%) patients; n
†Difference between total Aboriginal and total non-Aboriginal patients; NS
‡The total number of elective  urgent  emergent procedures is less than
or emergent status were unclear for some procedures.significantly greater frequency of diabetes, CRF, and ESRDthan non-Aboriginal patients (Table I). Only one (1%) Ab-
original patient and seven (1%) non-Aboriginal patients had
type 1 diabetes. Aboriginal and non-Aboriginal patients
had a similar frequency of cardiovascular, ophthalmologic,
and smoking risk factors (Table I).
Indications for surgery included rest pain and claudica-
tion significantly less frequently in Aboriginal than non-
Aboriginal patients (Table II). Gangrene and nonhealing
ulcers were significantly more frequent operative indica-
tions in Aboriginal than non-Aboriginal patients (Table II).
Acute ischemia was an uncommon surgical indication and
was similar for both patient groups (Table II). In the
non-Aboriginal patients, gangrene was a more common
surgical indication in diabetic than in nondiabetic patients
and in patients with chronic kidney disease than in those
with normal renal function (Table II).
The most frequently performed bypass operation in
pass procedures in 678 patients*
ginal patients Non-Aboriginal patients P value†
08 (100%) 720 (100%) .0001
36 (33%) 193 (27%) NS
12 (11%) 155 (22%) NS
6 (6%) 122 (17%) .0006
13 (12%) 105 (15%) NS
4 (4%) 98 (14%) .003
29 (27%) 34 (5%) .0001
8 (7%) 13 (2%) .0007
24 (22%) 81 (11%) .002
35 (32%) 54 (8%) .0001
6 (6%) 2 (0.3%) .0001
95 634
48 (51%) 406 (64%) .02
original, 720 (87%) procedures in 594 (88%) patients.
ignificant; P  .05.
tal number of procedures because available data regarding elective, urgent,
Table IV. Complications within 30 days of 828 lower
extremity vascular bypass procedures in 678 patients
Complication
No. Complications (% procedures)
Aboriginal Non-Aboriginal
Loss of limb 2 (2%) 4 (1%)
Myocardial infarction 2 (2%) 19 (3%)
Stroke 0 (0%) 3 (0.4%)
Wound infection 4 (4%) 25 (3%)
Graft occlusion 4 (4%) 12 (2%)
Postoperative bleeding 2 (2%) 11 (2%)
Death 2 (2%) 20 (33%)
There were a total of 828 procedures; Aboriginal, 108 procedures; non-
Aboriginal, 720 procedures.
For all complications, differences between Aboriginal and non-Aboriginal
patients was not significant.r by
Abori
1
on-Ab
, not sboth Aboriginal and non-Aboriginal patients was the fem-
isease
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had an amputation at or below the ankle level at the time of
the arterial bypass operation more frequently than non-
Aboriginal patients, including amputation of at least one
toe and forefoot amputation (Table III). In addition, by-
pass procedures were less frequently elective in Aboriginal
than in non-Aboriginal patients (Table III).
There was no difference between the Aboriginal and
non-Aboriginal groups in perioperative morbidity and
mortality within the first 30 days after surgery (Table IV).
Patient mortality at 5 years was similar for Aboriginal and
non-Aboriginal patients (Table V; Fig 1, A). Age was an
independent predictor of mortality, with an increased risk
for each year above the mean age, but age was not an
independent predictor of limb or graft survival. Patients
with CRF had a 2.6-fold greater risk of death within 5 years
of surgery compared with patients who did not have renal
disease (Table V). When adjusted for age, ESRD was not an
independent predictor of mortality.
Loss of limb was significantly more frequent in patients
with gangrene, reverse saphenous vein grafts, ESRD, and
emergency surgery than in those without these factors
(Table V; Fig 1, B). Although Aboriginal ethnicity and
Fig 1. Patient (A), limb (B), and graft survival (C) (cum
who had arterial reconstruction for peripheral vascular ddiabetes were significant risk factors for limb loss and loss ofgraft patency, multivariate analysis showed that these were
not significant independent risk factors for limb loss or loss
of graft patency (Table V). Gangrene, acute ischemia,
reverse saphenous vein graft, femoropopliteal (above-knee)
bypass, and ESRD were independent risk factors for loss of
primary graft patency (Table V; Fig 1, C).
DISCUSSION
The data show that the results of revascularization
surgery were worse for patients with chronic kidney disease
and those who presented with advanced vascular complica-
tions, regardless of group assignment. Neither Aboriginal
ethnicity nor diabetes was an independent risk factor for a
poor outcome (Table V). However, the Aboriginal patients
were younger and had a greater frequency of diabetes, CRF,
ESRD, gangrene, nonhealing ulcers, and toe and forefoot
amputation than non-Aboriginal patients (Tables I-III). T h e
similarity of patient mortality between Aboriginal and non-
Aboriginal patients (Table V) further indicates a greater
disease severity in the Aboriginal patients because of the
mean younger age compared with non-Aboriginal patients.
The finding that diabetes was not an independent risk
factor for patient mortality (Table V) is consistent with previ-
ve survival, %) in Aboriginal and non-Aboriginal patients
.ulatious work in patients undergoing revascularization.6,29,30 The
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effect on patient survival in Aboriginal patients compared
with non-Aboriginal patients, probably because the high
prevalence of diabetes in the Aboriginal group (Table I)
precluded an analysis of the effect of diabetes on outcomes.
However, previous studies suggest a greater effect of dia-
betes on minorities in general and on Aboriginals in partic-
ular.15,16,25 The observation that renal disease is an inde-
pendent risk factor for patient mortality in all patients
(Table V) is consistent with other reports of poorer survival
of patients with CRF or ESRD.9-11,17 Among this patient
population, however, ESRD, rather unexpectedly, was not
found to be an independent risk factor for patientmortality.
The majority of subjects with CRF or ESRD also had
diabetes, and results with ESRD and diabetes mirrored
those with ESRD alone (Fig).
Although the 5-year limb salvage and primary graft
patency rates were lower for Aboriginal patients than for
non-Aboriginal patients (Table V), multivariate analysis did
not find that Aboriginal ethnicity was an independent
predictor of a poor outcome. Although diabetes itself was
not shown to be an independent risk factor, diabetic com-
plications, such as gangrene, and chronic kidney disease,
with or without dialysis dependence, are more prevalent
and generally more severe among the Aboriginal patients.
Previous reports have shown a higher incidence of diabetes
Table V. Patient survival, limb salvage, and primary graft
procedures in 678 patients
Variable
Patient mortality
No. patients who died/total no. patients in category (%)
Aboriginal 20/84 (24%) Non-Aboriginal 160/
Diabetes 106/326 (33%) Nondiabetic 74/
CRF 36/79 (46%) No renal disease 144/
Loss of limb
No. procedures with loss of limb/total No. procedures in categ
Aboriginal 19/108 (18%) Non-Aboriginal 62
Diabetes 53/409 (13%) Nondiabetic 28
Gangrene 30/175 (17%) No gangrene 51
Saphenous* 21/105 (20%) In situ 25
ESRD 16/61 (26%) No dialysis 65
Emergency 31/275 (11%) Nonemergency 38
Loss of primary graft patency
No. procedures with loss of patency/total No. procedures in ca
Aboriginal 39/108 (36%) Non-Aboriginal 155/
Diabetes 116/409 (28%) Nondiabetic 78/
Gangrene 53/175 (30%) No gangrene 141/
Acute ischemia 23/66 (35%) No acute ischemia 171/
Saphenous* 36/105 (34%) In situ 66/
Fem-pop (AK)† 26/118 (22%) Other 168/
ESRD 46/61 (75%) No dialysis 148/
CI, Confidence interval; CRF, chronic renal failure; NS, not significant; ES
*Reverse saphenous vein graft vs in situ (prosthetic grafts were not directly
†Femoropopliteal bypass (above knee).and its complications (especially LEA) inminority populationscompared with the general population.15-19,31 Among these
minorities, people indigenous to North America have among
the highest prevalence of both diabetes and LEA.32-34
The influence of diabetes as a risk factor for LEA
diminishes with increasing age, particularly ages more than
65 years,21 and this may explain the limited effect of diabe-
tes on loss of limb in this study involving an older popula-
tion (Table I). Gangrene was more common among Ab-
original than non-Aboriginal patients and had a negative
effect on both limb salvage and primary patency (Table V),
presumably because gangrene indicates amore severemode
of presentation of PVD complications. In previous studies,
all amputations among Pima Indians with diabetes were
associated with gangrene,24 and infrapopliteal bypass pro-
cedures performed for gangrene in the general population
had a limb salvage rate of only 28% at 5 years.35 The poor
outcomes for both limb salvage and primary patency with
the reversed saphenous vein graft technique (Table V)
compared with in situ grafts are not consistent with an
established equivalency between the two procedures, as
stated in numerous articles.36,37 Although this is beyond
the scope of this study, it may be speculated that these
results reflect primarily surgeon-dependent issues rather
than study population issues.
The poorer limb salvage rate exhibited by Aboriginal than
non-Aboriginal patients also may, in part, be explained by the
cy at 5 years in 828 lower extremity vascular bypass
Univariate analysis Multivariate analysis
Hazard
ratio
P
value 95% CI
Relative
risk
P
value 95% CI
(27%) 1.0 NS 0.6–1.6 1.0 NS 0.6–1.6
(21%) 1.8 .0002 1.3–2.4 1.3 NS 0.9–1.7
(24%) 2.8 .0001 2.0–3.9 2.6 .0001 1.6–4.3
%)
(9%) 3.2 .0001 2.0–4.9 1.1 NS 0.5–2.2
(7%) 3.4 .0001 2.2–5.3 1.1 NS 0.6–1.9
(8%) 4.9 .0001 3.2–7.6 3.8 .0001 2.3–6.2
(7%) 3.9 .0001 2.3–6.5 2.0 .01 1.2–3.3
(8%) 5.2 .0001 3.3–8.4 1.8 .04 1.0–3.2
(8%) 2.2 .0006 1.4–3.4 1.6 .04 1.0–2.5
y (%)
(22%) 2.2 .0001 1.6–3.1 1.1 NS 0.7–1.7
(19%) 1.7 .0001 1.3–2.3 1.2 NS 0.8–1.6
(22%) 3.5 .0001 2.6–4.8 3.5 .0001 2.5–4.9
(22%) 2.1 .002 1.3–3.2 2.2 .001 1.4–3.5
(20%) 2.7 .0001 1.9–3.9 2.1 .0001 1.5–3.0
(24%) 2.6 .0002 1.6–4.5 1.5 .04 1.0–2.2
(19%) 5.3 .0001 3.3–8.4 1.8 .04 1.0–3.2
nd-stage renal disease (dialysis dependent).
ared because they were used only in the proximal bypasses).paten
594
352
599
ory (
/720
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/767
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compgreater frequency of Aboriginal patients with ESRD (Table I)
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The observed association of ESRD with poor limb salvage
outcomes is consistent with other reports, including studies in
Native American populations.8,17,20,38,39 Furthermore, Ab-
original patients had claudication less frequently, and may
have had greater delays in evaluation and treatment of
ischemia, than non-Aboriginal patients (Table II).
Although Aboriginal patients had worse outcomes
than non-Aboriginal patients for 5-year primary graft
patency, Aboriginal ethnicity was not an independent
risk factor for loss of patency. Furthermore, diabetic
patients had a lower 5-year primary patency rate than
nondiabetic patients, yet diabetes was not itself an inde-
pendent risk factor for loss of patency (Table V). Other
studies also have shown that diabetic patients are not at
increased risk for graft failure.29,30 However, ESRD was
an independent risk factor for loss of primary graft patency
(Table V), consistent with the reported low 5-year primary
patency rate for persons with ESRD of only 32%, which is
much lower than the patency rate (63%) reported without
this disease.9-11
Limitations of this study include those inherent with a
retrospective medical record review. Tobacco use is a risk
factor for death, LEA, and graft failure among similar
patient populations,11,12,17,37 but this was not demon-
strated in this study (data not shown), potentially because
of inaccuracy in characterizing former smoking histories by
pack-years or timing of tobacco use as either remote or
recent. The effects of renal disease may have been under-
stated because the designation of this risk factor was based
on the history in the medical record. In addition, the
classification of chronic kidney disease into dialysis inde-
pendent (CRF) and dialysis dependent (ESRD) does not
adequately characterize the spectrum of renal disease
among the study population in a way that can illustrate the
effect of the severity of the disease and its subsequent effect on
outcomes. Some Aboriginal patients may have been misclas-
sified as non-Aboriginal because of limited available informa-
tion about ethnic lineage. Furthermore, the effect of treat-
ment delay, especially that resulting from the large geographic
barriers to early treatment inherent with remote, rural, Ab-
original communities, could not be evaluated because of lim-
ited data in the medical record.
A combination of social and environmental factors
may account for the ethnic differences observed,18 and
some of the differences may have resulted from dispar-
ities in health literacy and timely access to health
care.1,31,40-42 Another explanation for the poorer lower
extremity outcomes for Aboriginal patients is that they
may have presented with PVD that more frequently
required popliteal to distal or femoral to pedal grafts
(Table III), thus indicating that the disease may have
involved the distal part of the leg more often than in
non-Aboriginal patients. The etiology, severity, ana-
tomic distribution, and more advanced presentation of
PVD complications among Aboriginal compared with
non-Aboriginal patients may be further evaluated by
lifestyle risk factor evaluation, pathoanatomic study, andan examination of the barriers to heath care among the
Aboriginal population.
The authors thank Carolyn Schlippert, Debbie Orm-
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